Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Moderna MRNA Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-124,199	Closed	-$8.3M	–	65
2024 Q3	$8.3M	Buy	124,199 +74,016	+147%	+$6.8M	0.69%	40
2024 Q2	$5.96M	Sell	50,183 -38,675	-44%	-$4.89M	0.54%	47
2024 Q1	$9.47M	Hold	88,858	–	–	0.82%	39
2023 Q4	$8.83M	Hold	88,858	–	–	0.61%	56
2023 Q3	$8.98M	Buy	88,858 +7,907	+10%	+$882K	0.66%	52
2023 Q2	$9.92M	Buy	80,951 +35,153	+77%	+$4.69M	0.7%	47
2023 Q1	$6.75M	Buy	+45,798	New	+$7.56M	0.54%	61

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's MRNA Position: Q4 2024 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of Moderna (MRNA) in Q4 2024, closing a stake of 124,199 shares — an estimated $8.3M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in MRNA in Q1 2023 and held it in 7 quarters. The position peaked at $9.92M in Q2 2023. 746 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 124,199 Moderna shares in Q4 2024, an estimated $8.3M.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in Moderna in Q1 2023 and held it in 7 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's Moderna position peaked at $9.92M in Q2 2023.
746 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q4 2024, filed 10 Feb 2025.